新股消息 | 传传奇生物(LEGN.US)拟在美国以外进行第二上市 香港为考虑地点之一

智通财经
Sep 08

智通财经APP获悉,据报道,由于投资者对制药商表现出浓厚兴趣,传奇生物(LEGN.US)正考虑在美国以外进行第二上市。报道引述知情人士称,可能上市地点包括香港、新加坡和伦敦。尤其是在香港上市的情况下,第二上市可能有助于提升传奇生物的估值。

报道指出,传奇生物仍在进行考虑中,可能决定不进行第二上市。传奇生物的代表不予置评。

传奇生物成立于2014年,2020年于美国纳斯达克上市。其主营肿瘤治疗领域CAR-T细胞免疫疗法,旗舰产品西达基奥仑赛已获美国FDA批准上市。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10